ROR2-v1 was the predominantly expressed isoform in both non-diseased tissues and among all 33 different tumour types profiled by TCGA (Figure 3B and Figure 4B) and hence this is the isoform that should primarily be examined when delineating the role of ROR2 in cancer. Here, ROR2 is linked to cancer.